Acelrx Pharmaceuticals Inc Stock Price (ACRX)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

: Infinity Pharmaceuticals upgraded to overweight from neutral at J.P. MorganMon, 2 Aug 2021 07:28:00 UTC via MarketWatch
Vertex Pharmaceuticals Incorporated 2021 Q2 - Results - Earnings Call PresentationFri, 30 Jul 2021 08:14:10 UTC via Seeking Alpha
Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q2 2021 Results - Earnings Call TranscriptThu, 29 Jul 2021 23:20:06 UTC via Seeking Alpha
Vertex Pharmaceuticals Incorporated (VRTX) CEO Reshma Kewalramani on Q2 2021 Results - Earnings Call TranscriptThu, 29 Jul 2021 23:11:07 UTC via Seeking Alpha
Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q2 2021 Results - Earnings Call TranscriptWed, 28 Jul 2021 22:40:19 UTC via Seeking Alpha
Why Is Infinity Pharmaceuticals Inc (NASDAQ: INFI) The Stock Of The Day?Wed, 28 Jul 2021 12:05:06 UTC via Yahoo Finance
: Acumen Pharmaceuticals started at buy with $27 stock price target at UBSMon, 26 Jul 2021 10:43:00 UTC via MarketWatch
BioCryst Pharmaceuticals - Orladeyo Revenue Will Drive Share PriceWed, 21 Jul 2021 23:04:00 UTC via Seeking Alpha
Zynerba Pharmaceuticals (ZYNE) Presents At HealthVirtual Conference - SlideshowFri, 16 Jul 2021 17:53:46 UTC via Seeking Alpha
Salarius Pharmaceuticals (SLRX) Investor Presentation - SlideshowFri, 16 Jul 2021 15:55:58 UTC via Seeking Alpha

Acelrx Pharmaceuticals Inc Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:ACRX

You don't have any alerts set for IEX:ACRX.

About Acelrx Pharmaceuticals Inc

AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. Its products include sufentanil, DZUVEO, DSUVIA ZALVISO US and ZALVISO EU. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.

CEOVincent J. Angotti IndustryPharmaceuticals: Other SectorHealth Technology Websitehttp://www.acelrx.com Issue ExchangeNASDAQ Issue TypeUnknown

Real-time ACRX to USD Trade Analysis on IEX

Market Status Open

Time Elapsed

Trades Analyzed

Last Price

Trades per Minute

Volume per Trade Average

Volume per Minute Average

Largest Trade Volume

Largest Trade Cost

Total Volume

Total Buy Volume

Total Sell Volume

Buy to Sell Volume

Buy to Sell Trades

USD per Trade Average

USD per Minute Average

USD Total Volume

Buy/Sell stats are based on the side that filled the order.

Real-time Trade History

Waiting for IEX trades to start ...

The last recorded trade was over an hour ago.